HIV/AIDS Clinical Trial
— MAKASIOfficial title:
MAKASI. An Intervention for African and Caribbean Migrants' Empowerment in Sexual Health in Order to Reduce Their Social and Health Vulnerabilities in Paris Greater Area
Background. Immigrants from Sub-Saharan Africa are the second group most affected by HIV in
France. Part of these HIV infections occurred after arrival in France, in relation to social
hardships. Immigrants coming from the non-French Caribbean islands face similar difficulties.
Many actors strive for an easier access to healthcare services for immigrants; however the
mere supply of knowledge and medicalised solutions is not enough to make persons adopt
prevention behaviours. It seems necessary to act upon empowerment to bring resources to
individuals and communities in order to improve their autonomy and action capacity. Civil
Society Organisations and researchers join forces in the MAKASI interventional research which
aims at reinforcing immigrants' empowerment in sexual health in order to reduce their
exposure to sexual risks.
Objectives : The MAKASI intervention consists in a unique Empowerment interview based on the
principles of motivational interviewing, using an Active Referral system to social or
sanitary services relevant to the person's needs. Our hypothesis is that this intervention is
going to reinforce four dimensions of empowerment in sexual health among immigrants: the
capacity to express their needs, competencies in sexual, self-esteem, awareness of exposure
to HIV and STIs. The proposed research aims at measuring the efficacy of the intervention on
these four dimensions, and at evaluating its processes and efficiency (cost-efficacy).
Methods: The intervention is delivered within the mobile units of Afrique Avenir in the
public spaces where African and Caribbean populations live and work. The evaluation uses
integrated mixed-method approach, combining a quantitative evaluation of impact and a
qualitative research on processes. The measure of impact will be done by comparing indicators
on the four dimensions of empowerment in sexual health and indicators of exposure to sexual
risks, between an arm where the intervention is immediate and an arm where the intervention
is differed by 3 months (control arm). The qualitative evaluation of the intervention
processes will be based upon an ethnographic approach of the intervention and the
participants' experience.
Perspectives: This project will demonstrate the efficacy and the efficiency of an innovative
intervention aiming at reducing Sub-Saharan and Caribbean immigrants' exposure to risks in
sexual health.
Status | Recruiting |
Enrollment | 1200 |
Est. completion date | January 31, 2021 |
Est. primary completion date | January 31, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Be aged at least 18 - HIV negative - Born in sub-Saharan Africa or the non-French Carribean - At least one of the eight vulnerability criteria: no stable house, no job, food deprivation, no papers, feeling isolated, not knowing where to go to to the doctor, no health insurance, experiencing violence Exclusion Criteria: - Does not speak French or English - Persons whose rapid HIV or HCV test is reactive - Persons who are not able to give an informed consent: bad mental health, persons who are on drugs |
Country | Name | City | State |
---|---|---|---|
France | Afrique Avenir Mobile Unit | Paris |
Lead Sponsor | Collaborator |
---|---|
French National Agency for Research on AIDS and Viral Hepatitis | Agence Regionale de Sante d'Ile de France |
France,
Gosselin A, Carillon S, Coulibaly K, Ridde V, Taéron C, Kohou V, Zouménou I, Mbiribindi R, Derche N, Desgrées du Loû A; MAKASI Study Group. Participatory development and pilot testing of the Makasi intervention: a community-based outreach intervention to improve sub-Saharan and Caribbean immigrants' empowerment in sexual health. BMC Public Health. 2019 Dec 5;19(1):1646. doi: 10.1186/s12889-019-7943-2. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change of unprotected sex | Declare unprotected sex at least once during the last three months (percent) | 0, 3 months, 6 months after inclusion | |
Primary | Change of transactional sex | Declare Transactional sex at least once during the last three months (percent) | 0, 3 months, 6 months after inclusion | |
Primary | Change of Forced sex | Declare having forced to have sex at least once during the last three months (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - Social Isolation | Feeling to be alone (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - Ability to talk | Empowerment - Perception of ability to talk about one's situation with a professional (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - Health insurance | Empowerment - having a health insurance (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - HIV test | Empowerment - Has been HIV tested | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - TASP knowledge | Empowerment - Knowledge that HIV treatment prevents from transmitting HIV | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - mental health score | Empowerment - PHQ 9 (Patient Health Questionnaire in 9 items) score : from 0 (good mental health) to 9 (very bad mental health) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - self-efficacy | Empowerment - feeling of control over the decisions that affect its life (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - HIV risk awareness | Empowerment - knowing that the risk of being HIV infected concerns everyone (percent) | 0, 3 months, 6 months after inclusion | |
Secondary | Empowerment - access to healthcare structure | Empowerment - having had access to a health structure when needed, in the last 3 months (percent) | 0, 3 months, 6 months after inclusion |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03413696 -
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
|
||
Completed |
NCT03289676 -
Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV
|
Phase 1 | |
Completed |
NCT03215901 -
Life Plans Intervention Study
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Active, not recruiting |
NCT04064567 -
Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK
|
N/A | |
Completed |
NCT04013295 -
Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT03984136 -
HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM
|
N/A | |
Completed |
NCT02928900 -
Patient Actor Training to Improve HIV Services for Adolescents in Kenya
|
N/A | |
Recruiting |
NCT03268109 -
COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
|
||
Completed |
NCT02797262 -
Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System
|
N/A | |
Completed |
NCT02376582 -
Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS
|
Phase 1 | |
Completed |
NCT01957865 -
Real-Time Antiretroviral Therapy Adherence Intervention in Uganda
|
N/A | |
Completed |
NCT01616940 -
Minority AIDS Initiative Retention and Re-Engagement Project
|
N/A | |
Terminated |
NCT01443923 -
Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV
|
Phase 4 | |
Completed |
NCT01910714 -
Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth
|
N/A | |
Completed |
NCT01084421 -
A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos
|
N/A | |
Completed |
NCT01596322 -
International HIV Antiretroviral Adherence, Resistance and Survival
|
N/A | |
Completed |
NCT03643705 -
A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention
|
N/A | |
Completed |
NCT03923231 -
Pharmacokinetics of Atazanavir in Special Populations
|